Katya Ascher

Subscribe to Katya Ascher's Posts
Katya Ascher focuses her practice on patent law issues in litigation and transactional matters across technology sectors. She regularly negotiates every type of agreement associated with technology transfer, research and development, manufacturing and distribution. She has over a decade of experience counseling clients in the United States, France, and the United Kingdom. Her clients include mid-sized companies and start-ups, operating in the biotechnology, pharmaceutical, medical device, and engineering fields. Read Katya Ascher's full bio.

Paris Court of Appeals Rejects Pharmaceutical Supplementary Protection Certificate Applications

By and on Jun 17, 2021
Posted In EU Update, Life Sciences

One of the conditions for obtaining an SPC is that “the product is protected by a basic patent in force”. The Court of Justice of the European Union (CJEU) clarified to what extent a product must be identified by the claims to meet this condition in Teva, Eli Lilly, and Royalty Pharma. In Eli Lilly,...

Continue Reading

IP Ownership Considerations in Multi-jurisdictional Software Development Agreements

By and on Jun 10, 2021
Posted In Copyrights, EU Update, Life Sciences, Patents, Trademarks

As a result of the healthcare sector’s growing dependence on software, health IT companies are increasingly taking advantage of globalisation to engage contractors in low wage jurisdictions to develop their user-facing software applications. This can trigger unforeseen legal risks owing to the differing laws across jurisdictions related to the ownership and transfer of intellectual property...

Continue Reading